International Center for Ethnobotanical Education, Research and Service

Last updated
International Center for Ethnobotanical Education, Research and Service (ICEERS)
Founded2009
Founder Benjamin de Loenen
Legal statusNon-profit organization
FocusResearch and advocacy on psychoactive plants (psychedelics, cannabis) and drug and substance use-related policies advocacy.
Location
Area served
Worldwide
Website www.iceers.org

The International Center for Ethnobotanical Education, Research, and Service (ICEERS) is a non-profit organization (NPO), headquartered in Barcelona (Catalonia, Spain). ICEERS is dedicated to transforming society's relationship with psychoactive plants by engaging with some of the fundamental issues resulting from the globalization of ayahuasca, iboga, and other ethnobotanicals. Founded in 2009, ICEERS is registered as a non-profit organization, and has charitable status in the Netherlands and Spain, and through partner organizations in the US and UK. [1] ICEERS also has consultative status with the United Nations' ECOSOC.

Contents

Vision

ICEERS envisions a future where psychoactive plant practices are valued and integrated parts of society. [1] Dedicated to turning challenges into opportunities, their vision is that of a future where society's relationship with these plants is transformed – where every individual and each community is granted the right to pursue healing and self-empowerment, where indigenous cultures are respected, and where bridges are built between traditional knowledge and science. [1] ICEERS is dedicated to bridging the ethnobotanical knowledge of indigenous peoples with modern science and therapeutic practice, responding to the urgent need for efficient tools for personal and social development. [2]

According to their website, the organization's mission includes:

History

The International Center for Ethnobotanical Education, Research & Service (ICEERS) was founded on May 20, 2009, by Benjamin De Loenen (director of the 2014 documentary Ibogaine-Rite of Passage) as a philanthropic, tax-exempt non-profit organization (charity) dedicated to the integration of ayahuasca, iboga and other traditional plants as therapeutic tools in modern society, and the preservation of indigenous cultures that have been using these plant species since antiquity. [4]

According to its founder and executive director, Benjamin de Loenen, "Over time more people joined the team with scientific and drug policy reform backgrounds, and we started to broaden our scope and address the subject matter from these different angles. Right now, we do scientific research, we also try to make science understandable for policy makers and broader audiences. We educate through the website, offering harm reduction and risk reduction information, and we are involved in policy reform." [5]

ICEERS has grown since 2009 from having a few volunteers and no budget at that time, to 14 staff in 2019. [6] In 2010, ICEERS offered their first training to health departments about ibogaine, as well as organizing a conference about this subject at the Catalan Health Department in that same year. [7] They have also engaged in relationship building and advocacy with decision-makers and international bodies at the United Nations. [8] In 2010, in a letter [9] responding to an ICEERS' query, the International Narcotics Control Board (INCB) confirmed that "no plant or concoction containing DMT, including ayahuasca, is currently under international control." [10] Moreover, ICEERS has participated in the development of important guidelines [11] for human rights and drug policy, led by the International Centre on Human Rights and Drug Policy, co-published by the WHO, UNDP and UNAIDS. They have also organized side-events at the Commission on Narcotic Drugs in Vienna for several years and have engaged several times at the UN Human Rights bodies in Geneva.[ citation needed ]

Between 2016 and 2019, the team supported more than 120 legal cases with plant medicine in 27 countries [12] through their legal defense program, the Ayahuasca Defense Fund, [13] creating positive legal precedents.

ICEERS has built a united, culturally diverse and international community [14] through the World Ayahuasca Conference, held in Ibiza, Spain, in 2014, Rio Branco, Brazil, in 2016, and in Girona, Spain, in 2019. The 2019 edition was the largest ever ayahuasca event in history with 1400 participants from 35 countries.[ citation needed ]

ICEERS has also seeded community self-regulatory processes in different countries [15] fostering collective responsibility, ethics, safety and efficient strategies towards regulation. [16]

In Catalonia and Spain, ICEERS has played a leading role advancing an integral cannabis regulation and creating spaces for the voices of medical cannabis patients and medical doctors in the political debate. [17]

Moreover, they have published dozens of scientific peer-reviewed papers, book chapters and other educational materials. [18] ICEERS has organized events at the United Nations, EMCDDA, numerous government agencies, and has presented at conferences worldwide. [19] In 2019, the Catalan Health Department commissioned ICEERS to write and publish a new informative guide on ayahuasca, [20] which is a compilation of basic ethical and security standards for the use of ayahuasca in non-Amazonian contexts and deals with areas of legality and both individual and collective responsibility.

Through their support service they have helped hundreds of people who have faced challenging or adverse experiences after the use of psychoactive plants and are leaders in developing approaches to the integration of psychedelic experiences. [21] Apart from that, they are committed to learning new ways of reciprocal alliance building with indigenous peoples, and gaining and sharing deeper understandings of the indigenous knowledge that surrounds these plants. [22] They collaborate with the Union of Indigenous Yagé Doctors of the Colombian Amazon, an organization created in 1999 that includes five indigenous ethnicities from southwestern Colombia that works to preserve the Amazon rainforest and to revitalize and protect cultures and ancestral medicines. [23]

Initiatives

Ayahuasca Defense Fund (ADF)

ICEERS has a decade of legal defense experience, which was formalized in 2016 with the launch of the Ayahuasca Defense Fund program. By September 2019, they had offered support in over 56 cases in 22 countries, several of which set positive legal precedents, and negative precedents were avoided in most other cases. [24] From 2008 to 2017, the ADF noted a significant increase in the legal incidents across the globe. [25] The ADF continues providing assistance around legal incidents, creating new supporting documents for legal teams, updating their online legal information, and developing new legal and human rights arguments based on previous casework.[ citation needed ]

Crisis Support

This service provides integration psychotherapy sessions for people in challenging situations after experiencing non-ordinary states of consciousness. ICEERS' support program has helped people worldwide to integrate challenging or adverse experiences since 2013. This donation-based offering was a pioneer in offering integration services and has provided a unique perspective into why and how these situations occur. Over time, they have analyzed and consolidated these key learnings in order to develop training programs [26] and an integration manual for practitioners and integration specialists.[ citation needed ]

CANNABMED

ICEERS is a generally trusted reference point for information on science and socio-political transformation. They have organized three CANNABMED conferences in 2016, 2018 and 2020. Through this process, they successfully supported cannabis patients to self-organize (they now have their own patient's organization, the Patients Union for Cannabis Regulation) and also bringing medical professionals together so that they can work together collectively.[ citation needed ]

CANNABMED has promoted the creation of a patient association [27] and a clinical society of professionals [28] interested in the therapeutic potential of cannabis. Hundreds of people with health problems have found a benchmark from CANNABMED and have organized to fight for their rights. [29]

CANNABMED events have provided a framework for civil society, health professionals and politicians to meet, discuss, and build relationships. [30] Since the first event, ICEERS has led several community development processes that resulted in the creation of two new actors in the cannabis regulation scene. First, a patient's union, [31] and in 2019, a health professional NGO that is now operating autonomously (the Endocannabinology Clinical Society [32] ). The first CANNABMED Congress was held at the Autonomous University of Barcelona (UAB), [33] the second one at the College of Physicians of Barcelona, [34] and the third at the College of Pharmacists of Barcelona. [35]

ICEERS has authored and collaborated in several publications about the topic of the Cannabis Social Clubs in Spain. [36] [37] [38] [39] [40] [41]

PsychēPlants

In 2017, ICEERS received an EU Commission grant for a project called PsychēPlants, through which they developed a series of reports [42] about psychoactive plants, fungi and animal secretions as well as a risk-reduction website to share this important information. This funding also resourced their support service for 18 months and funded a 4-hour course for the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction), as well as an online course for health professionals.[ citation needed ]

World Ayahuasca Conference

The first World Ayahuasca Conference was held in 2014 in Ibiza, Spain, and the second in 2016 in Rio Branco, capital of Acre, in Brazil. The third edition took place in Girona, Spain, from May 31 to June 2, 2019.

According to their website, the World Ayahuasca Conference is "much more than a conference. It is an instrument for social change – an opportunity to create alignment within the community so that we can co-create a positive future for these plant practices. It's an opportunity to cross-pollinate between different social movements, seeding new collaborations. And, importantly, it's an opportunity to shine a light on the intrinsic connection between the globalization of ayahuasca and the on-going resistance being waged by indigenous peoples against the destruction of sacred land – the Amazon rainforest – so essential for ecological balance." [43]

Iboga/ine Community Engagement Initiative

Practices with iboga and ibogaine are expanding. The cultural, social, and political contexts surrounding the human relationship to this plant and its alkaloids, are complex and ICEERS has sought to bring careful consideration to the impacts of their globalization. The Iboga/ine Community Engagement Initiative sought to engage with the global community [44] to crowdsource opinions and ideas about what an ideal future looks like for iboga and ibogaine in global society – from African and international stakeholders.

Biocultural conservation, regeneration and alliance building

ICEERS has been working to develop strategies to leverage more interest and capacity for efforts to conserve and regenerate the plants and indigenous knowledge systems of the Amazon, Gabon and beyond. [45] This work is enabled through collaborations with Dr Bronner's, RiverStyx Foundation, and the Union of Indigenous Yagé Doctors of the Colombian Amazon. [46]

Research

ICEERS builds bridges between traditional knowledge and science to address some of society's most challenging health conditions and to build a more connected society. [47] [48] ICEERS conducts scientific studies on the potential benefits of psychoactive plants, principally cannabis, ayahuasca, and ibogaine, public health, and the role of traditional medicine practices in Global Mental Health. [49] In order to embrace the complex systems in which these ethnobotanicals are embedded, the research team has carried out several studies [50] from a multidisciplinary approach, effectively combining different disciplines ranging from the biomedical research in lab settings to ethnographic explorations.[ citation needed ]

ICEERS, in collaboration with other institutions, published the Ayahuasca Technical Report, [51] as well as the most complete study [52] about neuropsychiatric long-term effects of ayahuasca, the first study [53] showing brain changes in long-term ayahuasca ceremony participants, studies about ayahuasca therapeutical potential, [54] theoretical reflections [55] regarding therapeutic potential of ethnobotanicals, and research in cannabis therapeutic potential for chronic diseases, among others. [56] ICEERS collaborates closely with the group of the Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, with the Medical Anthropology Research Center (MARC) at the Rovira i Virgili University, Tarragona, and with the Autonomous University of Madrid. ICEERS is initiating the first-ever clinical trials with ibogaine for opioid dependence [57] in collaboration with Tre Borràs Cabacés from the Hospital Sant Joan de Reus. [58]

Related Research Articles

<span class="mw-page-title-main">Ayahuasca</span> South American psychoactive brew

Ayahuasca is a South American psychoactive brew, traditionally used by Indigenous cultures and folk healers in Amazon and Orinoco basins for spiritual ceremonies, divination, and healing a variety of psychosomatic complaints. Originally restricted to areas of Peru, Brazil, Colombia and Ecuador, in the middle of 20th century it became widespread in Brazil in context of appearance of syncretic religions that uses ayahuasca as a sacrament, like Santo Daime, União do Vegetal and Barquinha, which blend elements of Amazonian Shamanism, Christianity, Kardecist Spiritism, and African-Brazilian religions such as Umbanda, Candomblé and Tambor de Mina, later expanding to several countries across all continents, notably the United States and Western Europe, and, more incipiently, in Eastern Europe, South Africa, Australia, and Japan.

<span class="mw-page-title-main">Psychedelic drug</span> Hallucinogenic class of psychoactive drug

Psychedelics are a subclass of hallucinogenic drugs whose primary effect is to trigger non-ordinary mental states and an apparent expansion of consciousness. Also referred to as classic hallucinogens or serotonergic hallucinogens, the term psychedelic is sometimes used more broadly to include various types of hallucinogens, such as those which are atypical or adjacent to psychedelia like salvia and MDMA, respectively. This article makes use of the narrower classical definition of psychedelics. Classic psychedelics generally cause specific psychological, visual, and auditory changes, and oftentimes a substantially altered state of consciousness. They have had the largest influence on science and culture, and include mescaline, LSD, psilocybin, and DMT.

<span class="mw-page-title-main">Entheogen</span> Psychoactive substances that induce spiritual experiences

Entheogens are psychoactive substances that induce alterations in perception, mood, consciousness, cognition, or behavior for the purposes of engendering spiritual development or otherwise in sacred contexts. Anthropological study has established that entheogens are used for religious, magical, shamanic, or spiritual purposes in many parts of the world. Entheogens have traditionally been used to supplement many diverse practices geared towards achieving transcendence, including divination, meditation, yoga, sensory deprivation, asceticism, prayer, trance, rituals, chanting, imitation of sounds, hymns like peyote songs, drumming, and ecstatic dance. The psychedelic experience is often compared to non-ordinary forms of consciousness such as those experienced in meditation, near-death experiences, and mystical experiences. Ego dissolution is often described as a key feature of the psychedelic experience.

<i>Tabernanthe iboga</i> Species of plant

Tabernanthe iboga (iboga) is an evergreen rainforest shrub native to Central Africa. A member of the Apocynaceae family indigenous to Gabon, the Democratic Republic of Congo, and the Republic of Congo, it is cultivated across Central Africa for its medicinal and other effects.

Bwiti is a spiritual discipline of the forest-dwelling Punu people and Mitsogo peoples of Gabon and by the Fang people of Gabon and Cameroon. Modern Bwiti incorporates animism, ancestor worship, and in some cases, Christianity, into a syncretistic belief system.

Psychedelic therapy refers to the proposed use of psychedelic drugs, such as psilocybin, MDMA, LSD, and ayahuasca, to treat mental disorders. As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials, with some exceptions.

<span class="mw-page-title-main">Harmala alkaloid</span> Group of chemical compounds

Harmala alkaloids are several alkaloids that increase effects of reward system neurotransmitter dopamine by acting as monoamine oxidase inhibitors (MAOIs). These alkaloids are found in the seeds of Peganum harmala, as well as leaves of tobacco and coffee beans. The alkaloids include harmine, harmaline, harmalol, and their derivatives, which have similar chemical structures, hence the name "harmala alkaloids". These alkaloids are of interest for their use in Amazonian shamanism, where they are derived from other plants. Harmine, once known as telepathine and banisterine, is a naturally occurring beta-carboline alkaloid that is structurally related to harmaline, and also found in the vine Banisteriopsis caapi. Tetrahydroharmine is also found in B. caapi and P. harmala. Dr. Alexander Shulgin has suggested that harmine may be a breakdown product of harmaline. Harmine and harmaline are reversible inhibitors of monoamine oxidase A (RIMAs). They can stimulate the central nervous system by inhibiting the metabolism of monoamine compounds such as serotonin and norepinephrine.

A smart shop is a retail establishment that specializes in the sale of psychoactive substances, usually including psychedelics, as well as related literature and paraphernalia. The name derives from the name "smart drugs", a class of drugs and food supplements intended to affect cognitive enhancements which are often sold in smart shops.

The Multidisciplinary Association for Psychedelic Studies (MAPS) is an American nonprofit organization working to raise awareness and understanding of psychedelic substances. MAPS was founded in 1986 by Rick Doblin and is now based in San Jose, California.

<span class="mw-page-title-main">Santo Daime</span> New religious movement

Santo Daime is a syncretic religion founded in the 1930s in the Brazilian Amazonian state of Acre by Raimundo Irineu Serra, known as Mestre Irineu. Santo Daime incorporates elements of several religious or spiritual traditions including Folk Catholicism, Kardecist Spiritism, African animism and indigenous South American shamanism, including vegetalismo.

<span class="mw-page-title-main">Ibogaine</span> Psychoactive substance found in plants in the family Apocynaceae

Ibogaine is a naturally occurring psychoactive substance found in plants in the family Apocynaceae such as Tabernanthe iboga, Voacanga africana, and Tabernaemontana undulata. It is a psychedelic with dissociative properties.

<span class="mw-page-title-main">Jonathan Ott</span> American ethnobotanist and writer

Jonathan Ott is an ethnobotanist, writer, translator, publisher, natural products chemist and botanical researcher in the area of entheogens and their cultural and historical uses, and helped coin the term "entheogen".

Sacrament of Transition is a new religious movement based in Slovenia, based on and promoting the sacramental use of the psychoactive plant Tabernanthe iboga and its psychoactive chemical constituent ibogaine. The founder of Sacrament of Transition is Marko Resinovic. The organization routinely sponsors psychedelic-related conferences and meetings.

The Beckley Foundation is a UK-based think tank and UN-accredited NGO, dedicated to activating global drug policy reform and initiating scientific research into psychoactive substances. The foundation is a charitable trust which collaborates with leading scientific and political institutions worldwide to design and develop research and global policy initiatives. It also investigates consciousness and its modulation from a multidisciplinary perspective, working in collaboration with scientists. The foundation is based at Beckley Park near Oxford, United Kingdom. It was founded in 1998, and is directed by Amanda Feilding, Countess of Wemyss.

Kenneth A. Symington of Cañal was a British-Cuban civic leader, the last National Executive Commissioner of the Asociación de Scouts de Cuba.

Dimitri Mugianis is a harm reductionist, activist, musician, poet, writer, anarchist, and psychedelic practitioner.

<span class="mw-page-title-main">Psychoactive drug</span> Chemical substance that alters nervous system function

A psychoactive drug, psychopharmaceutical, psychoactive agent, or psychotropic drug is a chemical substance that changes the function of the nervous system and results in alterations of perception, mood, cognition, and behavior. These substances may be used medically, recreationally, for spiritual reasons, or for research. Some categories of psychoactive drugs may be prescribed by physicians and other healthcare practitioners because of their therapeutic value.

<span class="mw-page-title-main">FAAAT think & do tank</span> Global think tank on drug policy reform

For Alternative Approaches to Addiction, Think & do tank is an international non-profit organization working on drug policy, created in 2015 and based in Paris, France.

This is an overview of the legality of ibogaine by country. Ibogaine is not included on the UN International Narcotics Control Board's Green List, or List of Psychoactive Substances under International Control. However, since 1989, it has been on the list of doping substances banned by the International Olympic Committee and the International Union of Cyclists because of its stimulant properties.

<span class="mw-page-title-main">MindMed</span> Psychedelic medicine biotech company

Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.

References

  1. 1 2 3 "About International Center for Ethnobotanical Education, Research Service". ICEERS. 21 December 2018.
  2. "Research". Psychedelic Society of Minnesota.
  3. "International Center for Ethnobotanical Education, Research & Service (ICEERS)". International Drug Policy Consortium. Archived from the original on May 10, 2015.
  4. "ICEERS (International Center for Ethnobotanical Education Research & Service)". The Beckley Foundation. 8 April 2016.
  5. "From Film Student to NGO Founder: An Interview with Benjamin De Loenen on the Founding of ICEERS". Psychedelic Times. 3 June 2016.
  6. "Who We Are". moishv.com. 2019.
  7. "¿Qué pasa con la ibogaína?". Cáñamo (in Spanish). April 2016.
  8. "ICEERS contribution to the Office of the High Commissioner for Human Rights on the implementation of the UNGASS joint commitment to effectively addressing and countering the world drug problem with regard to human rights" (PDF). OHCHR. 18 May 2018.
  9. "Letter from the INCB" (PDF). ICEERS.
  10. "Letter from ICEERS to OHCHR" (PDF). OHCHR. 11 May 2015.
  11. "ICEERS contribution to the Office of the High Commissioner for Human Rights on the implementation of the UNGASS joint commitment to effectively addressing and countering the world drug problem with regard to human rights" (PDF). OHCHR. 18 May 2018.
  12. "Ayahuasca Defense Fund Annual Report Sept 2017-Sept 2019" (PDF). ICEERS. June 2020.
  13. "ADF | Ayahuasca Defense Fund | Legal Support". ICEERS. 21 December 2018.
  14. "The First Indigenous Ayahuasca Conference (Yubaka Hayrá) in Acre Demonstrates Political, Cultural and Spiritual Resistance". Chacruna.net. 14 February 2019.
  15. Nemu, Danny (2014-10-09). "Aya2014: Joining Worlds for Bottom-up Self-regulation". Psychedelic Press. Retrieved 2021-02-04.
  16. "Ayahuasca in the Globalized World — AYA2014 Declaration". Plant Teachers. 20 January 2015.
  17. ""Los pacientes han de ser visibles y los médicos tomar conciencia: hay mucha gente que consume cannabis con finalidades medicinales y esto no se frenará"". Catalunya Plural (in Spanish). 30 May 2018.
  18. "Research & Innovation". ICEERS. 2018-12-22. Retrieved 2021-02-04.
  19. "ICEERS - YouTube". www.youtube.com. Retrieved 2021-02-04.
  20. "New Guide: "Towards Better Ayahuasca Practices"". ICEERS. 22 October 2019.
  21. "Marc Aixalà | From Integrating Experiences to Integrated Practice". YouTube.
  22. "Human Rights & Rights of Indigenous Peoples". ICEERS. 17 September 2019.
  23. "Las enseñanzas de los indígenas". Cáñamo (in Spanish). July 2018.
  24. "ADF Annual Reports | Ayahuasca Defense Fund". ICEERS. 25 June 2020.
  25. "ICEERS contribution to the Office of the High Commissioner for Human Rights on the implementation of the UNGASS joint commitment to effectively addressing and countering the world drug problem with regard to human rights" (PDF).
  26. "ADF Webinar#4: The Duty of Care - Best Ceremonial Practices". ICEERS. 2019-09-17. Retrieved 2021-02-04.
  27. "Nacimiento de la Unión de Pacientes por la Regulación del Cannabis". ICEERS (in European Spanish). 2 April 2018.
  28. "La Sociedad Clínica de Endocannabinología: una mirada científica". Cannabmed 2020 (in European Spanish). 6 October 2020.
  29. "UPRC". UPRC. Retrieved 2021-02-04.
  30. "III Congreso CANNABMED 2020: «Hacia una farmacopea cannábica»". Cannabmed 2020 (in European Spanish). Retrieved 2021-02-04.
  31. "UPRC". UPRC.
  32. "Sociedad Clínica de Endocannabinología | SCE". Sociedad Clínica de Endocannabionología (in Spanish).
  33. "El Congreso Cannabmed dará voz a los pacientes que utilizan el cannabis". www.comunicae.es (in Spanish).
  34. "II Congreso Cannabmed: un puente entre la medicina cannábica y los pacientes". lasDrogas.info (in Spanish). 5 April 2018.
  35. "III Congreso CANNABMED 2020: «Hacia una farmacopea cannábica»". Cannabmed 2020 (in European Spanish).
  36. Pardal, Mafalda; Decorte, Tom; Bone, Melissa; Parés, Òscar; Johansson, Julia (18 July 2020). "Mapping Cannabis Social Clubs in Europe" . European Journal of Criminology. 19 (5): 1016–1039. doi:10.1177/1477370820941392. S2CID   225626208.
  37. Legalizing cannabis : experiences, lessons and scenarios /. 10 June 2022.
  38. Parés-Franquero, Òscar; Jubert-Cortiella, Xavier; Olivares-Gálvez, Sergi; Díaz-Castellano, Albert; Jiménez-Garrido, Daniel F.; Bouso, José Carlos (10 June 2019). "Use and Habits of the Protagonists of the Story: Cannabis Social Clubs in Barcelona". Journal of Drug Issues. 49 (4): 607–624. doi:10.1177/0022042619852780. S2CID   196548453.
  39. Jansseune, Laurent; Pardal, Mafalda; Decorte, Tom; Franquero, Òscar Parés (5 December 2018). "Revisiting the Birthplace of the Cannabis Social Club Model and the Role Played by Cannabis Social Club Federations". Journal of Drug Issues. 49 (2): 338–354. doi:10.1177/0022042618815690. S2CID   81294133.
  40. Decorte, Tom; Pardal, Mafalda; Queirolo, Rosario; Boidi, Maria Fernanda; Sánchez Avilés, Constanza; Parés Franquero, Òscar (1 May 2017). "Regulating Cannabis Social Clubs: A comparative analysis of legal and self-regulatory practices in Spain, Belgium and Uruguay". International Journal of Drug Policy. 43: 44–56. doi:10.1016/j.drugpo.2016.12.020. hdl: 1854/LU-8509050 . ISSN   0955-3959. PMID   28189980. S2CID   3934108.
  41. "Innovation Born of Necessity: Pioneering Drug Policy in Catalonia". www.opensocietyfoundations.org.
  42. "Technical Report on Psychoactive Ethnobotanicals" (PDF).
  43. "AYA2019: An Instrument for Social Change and Building Community". World Ayahuasca Conference 2019. 10 April 2019.
  44. "Strengthening the Global Iboga Community through Engagement". ICEERS. 2019-05-30. Retrieved 2021-02-04.
  45. "Strategic Plan 2017" (PDF). 2019.
  46. "World Ayahuasca Conference 2019". World Ayahuasca Conference 2019.
  47. "Research & Innovation". ICEERS. 22 December 2018.
  48. Bouso, José Carlos; Sánchez-Avilés, Constanza (June 2020). "Traditional Healing Practices Involving Psychoactive Plants and the Global Mental Health Agenda: Opportunities, Pitfalls, and Challenges in the "Right to Science" Framework". Health and Human Rights. 22 (1): 145–150. ISSN   2150-4113. PMC   7348435 . PMID   32669796.
  49. "José Carlos Bouso at ResearchGate".
  50. "ICEERS at ResearchGate".
  51. Ayahuasca Technical Report 2017. 17 August 2017.
  52. Bouso, José Carlos; González, Débora; Fondevila, Sabela; Cutchet, Marta; Fernández, Xavier; Barbosa, Paulo César Ribeiro; Alcázar-Córcoles, Miguel Ángel; Araújo, Wladimyr Sena; Barbanoj, Manel J.; Fábregas, Josep Maria; Riba, Jordi (8 August 2012). "Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study". PLOS ONE. 7 (8): e42421. Bibcode:2012PLoSO...742421B. doi: 10.1371/journal.pone.0042421 . ISSN   1932-6203. PMC   3414465 . PMID   22905130. S2CID   17944911.
  53. Bouso, José Carlos; Palhano-Fontes, Fernanda; Rodríguez-Fornells, Antoni; Ribeiro, Sidarta; Sanches, Rafael; Crippa, José Alexandre S.; Hallak, Jaime E. C.; de Araujo, Draulio B.; Riba, Jordi (April 2015). "Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans". European Neuropsychopharmacology. 25 (4): 483–492. doi:10.1016/j.euroneuro.2015.01.008. ISSN   1873-7862. PMID   25637267. S2CID   8486874.
  54. Jiménez-Garrido, Daniel F.; Gómez-Sousa, María; Ona, Genís; Dos Santos, Rafael G.; Hallak, Jaime E. C.; Alcázar-Córcoles, Miguel Ángel; Bouso, José Carlos (2020). "Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination". Scientific Reports. 10 (1): 4075. Bibcode:2020NatSR..10.4075J. doi:10.1038/s41598-020-61169-x. ISSN   2045-2322. PMC   7057990 . PMID   32139811.
  55. Oña, Genís; Bouso, José Carlos (11 December 2019). "Therapeutic potential of natural psychoactive drugs for central nervous system disorders: A perspective from polypharmacology". Current Medicinal Chemistry. 26 (1): 53–68. doi:10.2174/0929867326666191212103330. ISSN   1875-533X. PMID   31830883. S2CID   209341022.
  56. Bouso, José C.; Jiménez-Garrido, Daniel; Ona, Genís; Woźnica, Damian; Dos Santos, Rafael G.; Hallak, Jaime E. C.; Paranhos, Beatriz A. P. B.; de Almeida Mendes, Felipe; Yonamine, Mauricio; Alcázar-Córcoles, Miguel Á; Farré, Magí (July 2020). "Quality of Life, Mental Health, Personality and Patterns of Use in Self-Medicated Cannabis Users with Chronic Diseases: A 12-Month Longitudinal Study". Phytotherapy Research. 34 (7): 1670–1677. doi:10.1002/ptr.6639. ISSN   1099-1573. PMID   32083789. S2CID   211230549.
  57. "Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification - Full Text View - ClinicalTrials.gov". Clinicaltrials.gov. 2 November 2020.
  58. ICH GCP (2022). "Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification".